ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HZNP Horizon Therapeutics Public Limited Company

116.30
0.00 (0.00%)
Mar 17 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 116.31
Ask Price 116.30
News -
Day High

Low
90.56

52 Week Range

High
116.38

Day Low
Company Name Stock Ticker Symbol Market Type
Horizon Therapeutics Public Limited Company HZNP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 116.30 20:00:00
Open Price Low Price High Price Close Price Prev Close
116.30 116.30
Trades Volume Avg Volume 52 Week Range
0 0 - 90.56 - 116.38
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 116.30 USD

Horizon Therapeutics Public Limited Company Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 26.63B - - - 52.34
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Horizon Therapeutics Pub... News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No HZNP Message Board. Create One! See More Posts on HZNP Message Board See More Message Board Posts

Historical HZNP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months115.35116.38115.27116.084,094,1580.950.82%
1 Year109.25116.3890.56108.112,480,2957.056.45%
3 Years91.15120.53557.8496.812,219,98725.1527.59%
5 Years27.85120.53522.6977.832,102,95888.45317.59%

Horizon Therapeutics Pub... Description

Horizon Therapeutics PLC is a specialty and generic drug manufacturing company. The company is focused on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company has two reportable segments: orphan and inflammation. Orphan segment consists of medicines such as TEPEZZA, KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, UPLIZNA, BUPHENYL, and QUINSAIR. Inflammation segment consists of PENNSAID 2%, DUEXIS, RAYOS, and VIMOVO. It generates the vast majority of its revenue from the United States.

Your Recent History

Delayed Upgrade Clock